Strain Report - Rat Genome Database
Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Strain: ACI/SegHsd

Symbol: ACI/SegHsd
Strain: ACI
Substrain: SegHsd
CRRD ID: 737892
RRID: CRRD_737892
Ontology ID: RS:0000032
Also known as: ACI (#4920); MDC-03-29
Type: inbred
Source: Envigo
Origin: This substrain is derived by Albert Segaloff of the Alton Ochsner Medical Foundation in 1956, now maintained by Harlan Sprague-Dawley, Inc.
Coat Color: Agouti
Last Known Status: Unknown
Research Usage Carcinogenesis; Estrogen-induced pituitary growth; Transplant immunology





Disease Annotations     Click to see Annotation Detail View


Phenotype Values via Phenominer
Options:  View chart  |  Download data table  |  View expanded data table

Clinical Measurement
body weight
liver wet weight
spleen wet weight
both testes wet weight
mammary tumor number
post-insult time to mammary tumor formation
absolute change in thymus weight
prostate gland wet weight
ventral prostate gland wet weight
pituitary gland wet weight
thymus wet weight
prostate tumorous lesion number
area of individual prostate tumorous lesion
area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio
percentage of study population developing unilateral renal agenesis during a period of time
percentage of study population developing ventral prostate tumorous lesions during a period of time
percentage of study population developing mammary tumors during a period of time
percentage of study population developing pituitary tumors during a period of time
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time
percentage of study population developing testis tumors during a period of time
percentage of study population developing bilateral testis tumors during a period of time
percentage of study population developing experimental autoimmune neuritis during a period of time
benign colorectal tumor number
benign colorectal tumor surface area measurement
percentage of study population developing benign colorectal tumors during a period of time
percentage of study population developing poorly differentiated malignant colorectal tumors during a period of time
percentage of study population developing well differentiated malignant colorectal tumors during a period of time
well differentiated malignant colorectal tumor number
well differentiated malignant colorectal tumor surface area measurement
poorly differentiated malignant colorectal tumor surface area measurement
binary logarithm of pituitary gland wet weight

References

References - curated
1. Bender K, etal., J Exp Anim Sci 1994 Aug;36(4-5):151-65.
2. Bonne A, etal., Mol Biol Rep 2003 Sep;30(3):173-6.
3. De Miglio MR, etal., Carcinogenesis. 2007 May 17;.
4. Gould KA, etal., Genetics 2004 Dec;168(4):2113-25.
5. Gould KA, etal., Mamm Genome. 2005 Nov;16(11):854-64. Epub 2005 Nov 11.
6. Gould KA, etal., Mamm Genome. 2006 May;17(5):451-64.
7. Harvell DM, etal., Carcinogenesis 2002 Jan;23(1):161-9.
8. Harvell DM, etal., Endocrine 2003 Jul;21(2):175-83.
9. Harvell DM, etal., J Nutr 2001 Nov;131(11 Suppl):3087S-91S.
10. Harvell DM, etal., Proc Natl Acad Sci U S A 2000 Mar 14;97(6):2779-84.
11. Heeley RP, etal., Mamm Genome 1998 Mar;9(3):198-203.
12. Institute for Animal Experimentation University of Tokushima School of Medicine
13. Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.
14. Kurz SG, etal., Endocrinology. 2008 Apr 17;.
15. Meng HC,etal., Arthritis Rheum. 2004 Aug;50(8):2695-705.
16. Personal communication with Harlan Laboratories
17. RGD Automated Pipelines
18. Saar K, etal., Nat Genet. 2008 May;40(5):560-6.
19. Schaffer BS, etal., Cancer Prev Res (Phila). 2013 Jan;6(1):59-69. doi: 10.1158/1940-6207.CAPR-12-0346-T. Epub 2012 Nov 14.
20. Schaffer BS, etal., Cancer Res. 2006 Aug 1;66(15):7793-800.
21. Shull JD, etal., Carcinogenesis. 1997 Aug;18(8):1595-601.
22. Shull JD, etal., Endocrinology 2001 Dec;142(12):5124-30.
23. Shull JD, etal., Mamm Genome. 2006 Jul;17(7):751-9. Epub 2006 Jul 14.
24. Shull JD, etal., Mamm Genome. 2007 Sep 18;.
25. Smits BM, etal., Genome Res. 2004 Jul;14(7):1285-90.
26. Spady TJ, etal., Endocrinology 1999 Jun;140(6):2828-35.
27. Spady TJ, etal., J Nutr 1999 Feb;129(2S Suppl):587S-590S.
28. van Dokkum RP, etal., Nephrol Dial Transplant 2000 Sep;15(9):1337-43.
29. Yamashita S, etal., Cancer Res 2005 Apr 1;65(7):2610-6.

Region

Strain QTL Data
Symbol Name Trait
Cia25 Collagen induced arthritis QTL 25 joint integrity trait   (VT:0010548)    
Cia26 Collagen induced arthritis QTL 26 joint integrity trait   (VT:0010548)    
Colcr1 Colorectal carcinoma resistance QTL 1 intestine integrity trait   (VT:0010554)    
Colcr2 Colorectal carcinoma resistance QTL 2 intestine integrity trait   (VT:0010554)    
Colcr3 Colorectal carcinoma resistance QTL 3 intestine integrity trait   (VT:0010554)    
Colcr4 Colorectal carcinoma resistance QTL4 intestine integrity trait   (VT:0010554)    
Colcr5 Colorectal carcinoma resistance QTL 5 intestine integrity trait   (VT:0010554)    
Colcr6 Colorectal carcinoma resistance QTL 6 intestine integrity trait   (VT:0010554)    
Colcr7 Colorectal carcinoma resistance QTL 7 intestine integrity trait   (VT:0010554)    
Colcr8 Colorectal carcinoma resistance QTL 8 intestine integrity trait   (VT:0010554)    
Colcr9 Colorectal carcinoma resistance QTL 9 intestine integrity trait   (VT:0010554)    
Colcs1 Colorectal carcinoma susceptibility QTL 1 intestine integrity trait   (VT:0010554)    
Emca1 Estrogen-induced mammary cancer QTL 1 mammary gland integrity trait   (VT:0010552)    
Emca2 Estrogen-induced mammary cancer QTL 2 mammary gland integrity trait   (VT:0010552)    
Emca4 Estrogen-induced mammary cancer QTL 4 mammary gland integrity trait   (VT:0010552)    
Emca5 Estrogen-induced mammary cancer QTL 5 mammary gland integrity trait   (VT:0010552)    
Emca6 Estrogen-induced mammary cancer QTL 6 mammary gland integrity trait   (VT:0010552)    
Emca7 Estrogen-induced mammary cancer QTL 7 mammary gland integrity trait   (VT:0010552)    
Emca8 Estrogen-induced mammary cancer QTL 8 mammary gland integrity trait   (VT:0010552)    
Ept1 Estrogen-induced pituitary tumorigenesis QTL 1 pituitary gland mass   (VT:0010496)    
Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 pituitary gland mass   (VT:0010496)    
Ept13 Estrogen-induced pituitary tumorigenesis QTL 13 pituitary gland mass   (VT:0010496)    
Ept2 Estrogen-induced pituitary tumorigenesis QTL 2 pituitary gland mass   (VT:0010496)    
Ept5 Estrogen-induced pituitary tumorigenesis QTL 5 pituitary gland mass   (VT:0010496)    
Ept6 Estrogen-induced pituitary tumorigenesis QTL 6 pituitary gland mass   (VT:0010496)    
Ept7 Estrogen-induced pituitary tumorigenesis QTL 7 pituitary gland mass   (VT:0010496)    
Ept9 Estrogen-induced pituitary tumorigenesis QTL 9 pituitary gland mass   (VT:0010496)    
Esta1 Estrogen-induced thymic atrophy QTL 1 thymus mass   (VT:0004954)    
Esta2 Estrogen-induced thymic atrophy QTL 2 thymus mass   (VT:0004954)    
Esta3 Estrogen-induced thymic atrophy QTL 3 thymus mass   (VT:0004954)    
Eutr1 Estrogen induced uterine response QTL 1 uterus integrity trait   (VT:0010575)    
Prcr1 Prostate cancer resistance QTL 1 prostate integrity trait   (VT:0010571)    
Prcr2 Prostate cancer resistance QTL 2 prostate integrity trait   (VT:0010571)    
Prcs1 Prostate cancer susceptibility QTL 1 prostate integrity trait   (VT:0010571)    
Prcs2 Prostate cancer susceptibility QTL 2 prostate integrity trait   (VT:0010571)    
Renag1 Renal agenesis QTL 1 kidney development trait   (VT:0000527)    
Tescar1 Testicular tumor resistance QTL 1 testis integrity trait   (VT:0010572)    

Additional Information

RGD Curation Notes
Note Type Note Reference
strain_anatomy ACI rats, both males and females, exhibit unilateral renal agenesis (URA) at an incidence of 5-15% 1580355
strain_drgs_chems Synthetic estrogen diethylstilbestrol (DES) induces pituitary growth in ACI and COP rats and their F1, F2 and backcross progeny. 1358974
strain_drgs_chems DES induces an increase in the circulating PRL in ACI males as compared to COP males. 1358974
strain_drgs_chems These develop three times less severe hypertension and renal damage when given the same dose of L-NAME as compared to FHH/EURMcwi rats. 1357424
strain_drgs_chems 17beta-estradiol stimulates lactotroph proliferation and induces pituitary tumors. 1358974
strain_drgs_chems 17beta-estadiol induces mammary tumorigenesis in females, 100% of the population exhibited palpable mammary tumors. 1358954
strain_drgs_chems resistant to estrogen diethylstilbestrol (DES) induced thymic atrophy in comparison to BN strain 1579780
strain_life_disease These are resistant to collagen-induced arthritis and when mated with DA develop similar disease severity. 1285224
strain_life_disease These are resistant to renal damage. 1357424
strain_life_disease DES induces 2-fold greater growth response in the anterior pituitary gland as compared to COP rats. 1358974
strain_life_disease 17beta-estradiol stimulates mammary cell proliferation and lobuloalveolar hyperplasia. These also exhibit aneuploidy. 1358963
strain_life_disease E2 induced atypical epithelial hyperplasia in the mammary cells which is not present in COP rats. 1358963
strain_life_disease F1, F2 and backcross progeny of these rats with COP show significantly prolonged latency for E2 induced mammary cancer. 1358956
strain_life_disease Susceptibility to E2-induced mammary cancer does not correlate with E2-induced pituitary growth. 1358956
strain_life_disease Dietary energy consumption inhibits mammary carcinogenesis even when the circulating E2 in high. 1358957
strain_life_disease Dietary energy consumption inhibits mammary carcinogenesis even when the circulating E2 in high. 1358973
strain_life_disease spontaneously develop a high incidence of microscopic cancers of the ventral prostate with aging 1358944
strain_life_disease Resistant to estrogen-induced uterine inflammation and infection (pyometritis) 1559292
strain_other DA/BklArb rats have A allele and ACI/SegHsd have a G allele at nucleotide 316 (codon 106) and DA/BklArb rats have T allele and ACI/SegHsd have a C allele at nucleotide 458 (codon 153) that cause amino acid change which is responsible for arthritis-susceptible and resistant SNPs that correlated with variable production of reactive oxygen species 1285224
strain_other 12 weeks of E2 treatment in females exhibit an increase in pituitary weight and circulating PRL. 1358963
strain_other E2-induced mammary carcinogenesis is mapped to rat chromosome 5 to the Emca1 region which has the Cdkn2a tumor suppressor gene. 1358957
strain_other These have shorter survival time after controlled hemorrhage than BN/HsdMcwiCrl but longer than DA/OlaHsd. 2302114
strain_phys_biochem This strain was screened for genetic polymorphisms for 100 genomic loci in 55 genes ; Polymorphisms observed in this study can be found in NCBI dbSNP under accession numbers ss12588106 - ss12588203. 737878
strain_phys_biochem Dietary energy restrictions inhibit mammary tumorigenesis which is tissue specific and is independent of circulating E2 and prolactin-producing pituitary tumors. 1358954

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2015-10-12 ACI/SegHsd    ACI/SegHsd    Name updated 68913 APPROVED
2015-10-12 ACI/SegHsd    ACI/SegHsd    Name updated 68913 APPROVED
2015-10-12 ACI/SegHsd    ACI/SegHsd    Name updated 68913 APPROVED
2015-10-12 ACI/SegHsd    ACI/SegHsd    Name updated 68913 APPROVED
2014-09-25 ACI/SegHsd    ACI/SegHsd    Name updated 68913 APPROVED
2014-09-25 ACI/SegHsd    ACI/SegHsd    Name updated 68913 APPROVED

 



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.